These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 26868493)
1. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Donath MY Diabetologia; 2016 Apr; 59(4):679-82. PubMed ID: 26868493 [TBL] [Abstract][Full Text] [Related]
2. Lipids and immunoinflammatory pathways of beta cell destruction. Imai Y; Dobrian AD; Morris MA; Taylor-Fishwick DA; Nadler JL Diabetologia; 2016 Apr; 59(4):673-8. PubMed ID: 26868492 [TBL] [Abstract][Full Text] [Related]
3. Mitochondrial network regulation and its potential interference with inflammatory signals in pancreatic beta cells. Baltrusch S Diabetologia; 2016 Apr; 59(4):683-7. PubMed ID: 26873508 [TBL] [Abstract][Full Text] [Related]
4. The role of leptin in diabetes: metabolic effects. Meek TH; Morton GJ Diabetologia; 2016 May; 59(5):928-32. PubMed ID: 26969486 [TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease. Esser N; Paquot N; Scheen AJ Expert Opin Investig Drugs; 2015 Mar; 24(3):283-307. PubMed ID: 25345753 [TBL] [Abstract][Full Text] [Related]
7. Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes? Sathyapalan T; Atkin SL Minerva Endocrinol; 2011 Jun; 36(2):147-56. PubMed ID: 21519323 [TBL] [Abstract][Full Text] [Related]
8. Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis. Perry RJ; Petersen KF; Shulman GI Diabetologia; 2016 May; 59(5):933-7. PubMed ID: 26961503 [TBL] [Abstract][Full Text] [Related]
9. Glucagon action in the brain. Abraham MA; Lam TKT Diabetologia; 2016 Jul; 59(7):1367-1371. PubMed ID: 27115416 [TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptors as new therapeutic targets for type 2 diabetes. Reimann F; Gribble FM Diabetologia; 2016 Feb; 59(2):229-33. PubMed ID: 26661410 [TBL] [Abstract][Full Text] [Related]
11. Renaissance of leptin for obesity therapy. Quarta C; Sánchez-Garrido MA; Tschöp MH; Clemmensen C Diabetologia; 2016 May; 59(5):920-7. PubMed ID: 26983921 [TBL] [Abstract][Full Text] [Related]
12. Sources of beta cells inside the pancreas. De Groef S; Staels W; Van Gassen N; Lemper M; Yuchi Y; Sojoodi M; Bussche L; Heremans Y; Leuckx G; De Leu N; Van de Casteele M; Baeyens L; Heimberg H Diabetologia; 2016 Sep; 59(9):1834-7. PubMed ID: 27053238 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications. Pollack RM; Donath MY; LeRoith D; Leibowitz G Diabetes Care; 2016 Aug; 39 Suppl 2():S244-52. PubMed ID: 27440839 [TBL] [Abstract][Full Text] [Related]
14. Targeting inflammation in the treatment of type 2 diabetes: time to start. Donath MY Nat Rev Drug Discov; 2014 Jun; 13(6):465-76. PubMed ID: 24854413 [TBL] [Abstract][Full Text] [Related]
15. Treatment of gastrointestinal autonomic neuropathy. Törnblom H Diabetologia; 2016 Mar; 59(3):409-13. PubMed ID: 26634570 [TBL] [Abstract][Full Text] [Related]
17. Nutritional anti-inflammatories in the treatment and prevention of type 2 diabetes mellitus and the metabolic syndrome. Merone L; McDermott R Diabetes Res Clin Pract; 2017 May; 127():238-253. PubMed ID: 28402903 [TBL] [Abstract][Full Text] [Related]
18. [Chronic inflammation can cause type 2 diabetes]. Sjöholm A; Nyström T Lakartidningen; 2004 May; 101(19):1716-21. PubMed ID: 15188586 [No Abstract] [Full Text] [Related]